1.Analysis of synovial fluid Asporin levels in patients with temporomandibular joint disorders
Lei ZHANG ; Haiwei BU ; Tianyu XU ; Mingxu ZHANG ; Ping NIU ; Feng HUO ; Rui LIU
STOMATOLOGY 2025;45(7):525-528
Objective To investigate the changes and clinical significance of synovial fluid Asporin level in patients with tem-poromandibular joint disorders(TMD).Methods A total of 48 TMD patients who were treated in our hospital from January 2021 to December 2023 due to irritant pain and mouth opening limitation were randomly selected as the observation group,and 48 healthy vol-unteers were selected as the control group.The synovial fluid Asporin levels of the two groups were detected by enzyme-linked immu-nosorbent assay(ELISA).The difference of synovial fluid Asporin levels between the two groups was compared.The correlation be-tween the synovial fluid Asporin levels and the clinical symptoms of TMD was analyzed.Results The synovial fluid Asporin level in the experimental group was significantly higher than that in the control group(P<0.05).The synovial fluid Asporin level was positively correlated with the pain degree of TMD patients(Rs=0.825,P<0.001),negatively correlated with the degree of mouth opening(Rs=-0.945,P<0.001).Conclusion The level of Asporin in synovial fluid of TMD patients was significantly increased.The level of As-porin in synovial fluid of TMD patients is correlated with the clinical symptoms of TMD,which provides a basis for the diagnosis and evaluation of TMD.
2.Analysis of synovial fluid Asporin levels in patients with temporomandibular joint disorders
Lei ZHANG ; Haiwei BU ; Tianyu XU ; Mingxu ZHANG ; Ping NIU ; Feng HUO ; Rui LIU
STOMATOLOGY 2025;45(7):525-528
Objective To investigate the changes and clinical significance of synovial fluid Asporin level in patients with tem-poromandibular joint disorders(TMD).Methods A total of 48 TMD patients who were treated in our hospital from January 2021 to December 2023 due to irritant pain and mouth opening limitation were randomly selected as the observation group,and 48 healthy vol-unteers were selected as the control group.The synovial fluid Asporin levels of the two groups were detected by enzyme-linked immu-nosorbent assay(ELISA).The difference of synovial fluid Asporin levels between the two groups was compared.The correlation be-tween the synovial fluid Asporin levels and the clinical symptoms of TMD was analyzed.Results The synovial fluid Asporin level in the experimental group was significantly higher than that in the control group(P<0.05).The synovial fluid Asporin level was positively correlated with the pain degree of TMD patients(Rs=0.825,P<0.001),negatively correlated with the degree of mouth opening(Rs=-0.945,P<0.001).Conclusion The level of Asporin in synovial fluid of TMD patients was significantly increased.The level of As-porin in synovial fluid of TMD patients is correlated with the clinical symptoms of TMD,which provides a basis for the diagnosis and evaluation of TMD.
3.Correlation Analysis Between Admission Blood Glucose Level and Long-term Prognosis in Patients With Acute Coronary Syndrome
Minghui WANG ; Haiwei BU ; Wanglexian SUN ; Ying ZHANG ; Jie ZHAO ; Wenfeng WANG ; Shucheng LI ; Na ZHANG ; Chunhua LI
Chinese Circulation Journal 2016;31(10):970-975
Objective: To investigate the correlation between admission blood glucose (ABG) level and long-term prognosis in patients with acute coronary syndrome (ACS) without diabetes mellitus (DM). Methods: A total of 585 ACS patients received percutaneous coronary intervention (PCI) in our hospital from 2014-01 to 2015-10 were consecutively enrolled and no one combined with DM. Based on ABG levels, the patients were divided into 2 groups:ABG≥7.0 mmol/L group,n=133 and ABG<7.0 mmol/L group,n=452. Demographic, clinical data and treatment conditions were collected to conduct follow-up study and to assess the prognosis. Results: The median follow-up time was 350 days and all cause death in ABG≥7.0 mmol/L group and ABG<7.0 mmol/L group was 2.4% vs 0.9%,P>0.05. Compared with ABG<7.0 mmol/L group, the patients in ABG≥7.0 mmol/L group had the higher incidences of MACE, PCI complication, recurrence of angina and more re-admissions for cardiac event, all P<0.05.Cox regression mode lanalysis in dicated that in addition to acute STEMI (HR=2.016), malignant arrhythmia (HR=3.028) and previous MI history (HR=2.293), blood glucose≥7.0mmol/L was also an independent risk factor for poor long-term prognosis in relevant patients. Conclusion: ABG≥7.0 mmol/L implies poor long-term prognosis in ACS patients and special attention is necessary in secondary prevention.

Result Analysis
Print
Save
E-mail